Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

28.41
-0.4000-1.39%
Post-market: 27.90-0.5079-1.79%16:26 EDT
Volume:535.98K
Turnover:15.37M
Market Cap:1.35B
PE:9.28
High:29.34
Open:28.64
Low:28.22
Close:28.81
Loading ...

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
08 Nov 2024

Stock Track | Amphastar Shares Plunge as Q3 Earnings Miss Rattles Investors

Stock Track
·
08 Nov 2024

Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
08 Nov 2024

Stock Track | Amphastar Pharmaceuticals Shares Plunge on Disappointing Q3 Earnings, Cost Pressures

Stock Track
·
07 Nov 2024

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...

GuruFocus.com
·
07 Nov 2024

Stock Track | Amphastar Pharmaceuticals Misses Q3 Earnings Estimates, Stock Plunges

Stock Track
·
07 Nov 2024

Amphastar Pharmaceuticals Reports Strong Q3 2024 Results

TIPRANKS
·
07 Nov 2024

Amphastar Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Zacks
·
07 Nov 2024

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Zacks
·
07 Nov 2024

Amphastar: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

Amphastar Pharma Q3 2024 Adj EPS $0.96 Misses $0.99 Estimate, Sales $191.20M Miss $194.69M Estimate

Benzinga
·
07 Nov 2024

Amphastar Pharmaceuticals Q3 EPS USD 0.78

THOMSON REUTERS
·
07 Nov 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

ACCESSWIRE
·
07 Nov 2024

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks
·
31 Oct 2024

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
30 Oct 2024